Syk expression and IgE-mediated histamine release in basophils as biomarkers for predicting the clinical efficacy of omalizumab

Donald W. MacGlashan; Sarbjit S. Saini

doi:10.1016/j.jaci.2016.12.965

Syk expression and IgE-mediated histamine release in basophils as biomarkers for predicting the clinical efficacy of omalizumab

Donald W. MacGlashan, Sarbjit S. Saini

School of Medicine

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Original language	English (US)
Pages (from-to)	1680-1682.e10
Journal	Journal of Allergy and Clinical Immunology
Volume	139
Issue number	5
DOIs	https://doi.org/10.1016/j.jaci.2016.12.965
State	Published - May 2017

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1016/j.jaci.2016.12.965

Cite this

@article{4701193331dd4ea686a518771f3d77db,

title = "Syk expression and IgE-mediated histamine release in basophils as biomarkers for predicting the clinical efficacy of omalizumab",

author = "MacGlashan, {Donald W.} and Saini, {Sarbjit S.}",

year = "2017",

month = may,

doi = "10.1016/j.jaci.2016.12.965",

language = "English (US)",

volume = "139",

pages = "1680--1682.e10",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Mosby Inc.",

number = "5",

}

TY - JOUR

T1 - Syk expression and IgE-mediated histamine release in basophils as biomarkers for predicting the clinical efficacy of omalizumab

AU - MacGlashan, Donald W.

AU - Saini, Sarbjit S.

PY - 2017/5

Y1 - 2017/5

UR - http://www.scopus.com/inward/record.url?scp=85014062400&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014062400&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2016.12.965

DO - 10.1016/j.jaci.2016.12.965

M3 - Article

C2 - 28259446

AN - SCOPUS:85014062400

SN - 0091-6749

VL - 139

SP - 1680-1682.e10

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 5

ER -

Syk expression and IgE-mediated histamine release in basophils as biomarkers for predicting the clinical efficacy of omalizumab

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this